Skip to main content
. 2021 Mar 24;43(4):1835–1849. doi: 10.1007/s11357-021-00359-5

Table 1.

Characteristics of study participants by age at round 1

30 years 40 years 50 years 60 years
n = 547 n = 622 n = 612 n = 395
Demographics and lifestyle
Age (years) 30.8 (30.6–31.0) 40.8 (40.6–40.9) 50.8 (50.6–50.9) 60.8 (60.6–60.9)
Male (%) 260 (47.5) 304 (48.9) 313 (51.1) 171 (43.3)
Daily smoker (%) 298 (54.5) 292 (47.0) 319 (52.1) 145 (36.7)
BMI (kg/m2) 22.3 (20.6–24.5) 23.7 (21.8–26.3) 24.8 (22.7–27.4) 25.0 (22.8–27.2)
Physical activity level
Almost completely inactive (%) 145 (26.5) 161 (25.9) 144 (23.5) 82 (20.8)
Some physical activity (%) 273 (49.9) 299 (48.1) 336 (54.9) 234 (59.2)
Regular activity (%) 107 (19.6) 148 (23.8) 131 (21.4) 79 (20.0)
Regular hard physical training (%) 22 (4.0) 14 (2.3) 1 (0.2) 0 (0.0)
Cardiovascular risk factors
Diabetes (%) 2 (0.4) 7 (1.1) 12 (2.0) 8 (2.0)
Cardiovascular disease (%) 10 (1.8) 13 (2.1) 21 (3.4) 22 (5.6)
Hypertension (%) 56 (10.2) 83 (13.3) 84 (13.7) 79 (20.0)
Total cholesterol (mmol/L) 5.2 (4.7–5.8) 5.7 (5.1–6.5) 6.3 (5.6–7.0) 6.7 (6.0–7.5)
HDL cholesterol (mmol/L) 1.4 (1.2–1.7) 1.5 (1.2–1.8) 1.5 (1.2–1.8) 1.6 (1.3–1.9)
Biomarkers of organ function
CRP (mg/L) 0.8 (0.4–1.7) 0.9 (0.5–1.9) 1.3 (0.6–2.8) 1.7 (0.8–3.2)
Cystatin C (mg/L) 0.7 (0.6–0.7) 0.7 (0.6–0.7) 0.7 (0.7–0.8) 0.8 (0.7–0.9)
eGFR (mL/min/1.73m2) 115.3 (105.3–119.7) 106.5 (97.2–111.2) 97.6 (85.3–103.5) 87.8 (76.7–95.6)
AST (U/L) 25.0 (19.9–31.0) 25.0 (20.0–31.74) 26.0 (21.0–32.0) 29.0 (23.0–35.0)
GGT (U/L) 18.0 (14.0–30.0) 21.0 (14.0–35.0) 24.0 (16.49–42.0) 26.0 (18.0–40.0)
hs-cTnI (ng/L) 2.3 (1.4–3.6) 2.2 (1.3–3.4) 2.3 (1.4–3.5) 3.1 (2.1–4.8)

Data are presented as median (interquartile range) or n (%).

AST, aspartate transaminase; BMI, body mass index; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; hs-cTnI, high-sensitive troponin I; GGT, gamma-glutamyl transferase